{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "0dab23b4",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "id": "1c134968",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <th>2013-07-04 08:44:42.278539265</th>\n",
       "      <th>2013-07-04 04:22:03.305394179</th>\n",
       "      <th>2013-07-03 21:48:41.159868423</th>\n",
       "      <th>2013-07-03 15:55:15.081797632</th>\n",
       "      <th>2013-07-03 04:25:53.837944834</th>\n",
       "      <th>...</th>\n",
       "      <th>1987-06-22 19:36:28.372967425</th>\n",
       "      <th>1987-06-22 13:38:05.220745216</th>\n",
       "      <th>1987-06-20 01:14:46.517178368</th>\n",
       "      <th>1987-06-19 13:30:22.587748353</th>\n",
       "      <th>1987-06-19 13:03:48.404117505</th>\n",
       "      <th>1987-06-19 12:17:53.643945985</th>\n",
       "      <th>1987-06-19 12:06:26.675290112</th>\n",
       "      <th>1987-06-17 23:05:41.186953217</th>\n",
       "      <th>1987-06-17 15:18:00.525635584</th>\n",
       "      <th>1987-06-13 10:44:06.537678849</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>tweet_author</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>1stOncology</td>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>David Ledger</td>\n",
       "      <td>N Wales Cancer Forum</td>\n",
       "      <td>European Pharmaceutical Review</td>\n",
       "      <td>Graham Collins</td>\n",
       "      <td>CLL Ireland</td>\n",
       "      <td>...</td>\n",
       "      <td>C A R E N</td>\n",
       "      <td>Werneth Cricket</td>\n",
       "      <td>John P. Leonard, MD</td>\n",
       "      <td>Joy is a Lifestyle</td>\n",
       "      <td>Miche√°l üáÆüá™</td>\n",
       "      <td>Joy is a Lifestyle</td>\n",
       "      <td>ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ</td>\n",
       "      <td>IQWiG</td>\n",
       "      <td>Medibooks</td>\n",
       "      <td>Medibooks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tweet_text</th>\n",
       "      <td>‚öïÔ∏è Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>NICE backs AstraZeneca‚Äôs Calquence for CLL htt...</td>\n",
       "      <td>This is England for now - these decisions usua...</td>\n",
       "      <td>AstraZeneca‚Äôs Calquence (acalabrutinib), a che...</td>\n",
       "      <td>Superstar @tobyeyre82 responding to the excell...</td>\n",
       "      <td>CLL patients all know the drug Ibrutinib and y...</td>\n",
       "      <td>...</td>\n",
       "      <td>I miss them! üòãüòÜüòÖ\\n\\n#FotoRus #FriendshipForeve...</td>\n",
       "      <td>The fixtures are out, first team will travel t...</td>\n",
       "      <td>Partnering @GileadSciences &amp;amp;Ono BTKi-combo...</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>What I'd do to go to Gerrard's last game at An...</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>Zusatznutzen von #Idelalisib ist weder f√ºr #CL...</td>\n",
       "      <td>#Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...</td>\n",
       "      <td>#Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows √ó 43347 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  2013-07-18 09:39:46.071961602  \\\n",
       "tweet_author                                 Hematopoiesis News   \n",
       "tweet_text    ‚öïÔ∏è Scientists conducted a Phase II study of ac...   \n",
       "\n",
       "                                  2013-07-17 03:40:32.173842437  \\\n",
       "tweet_author                                   Michael Wang, MD   \n",
       "tweet_text    This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "\n",
       "                                  2013-07-15 15:41:16.553048065  \\\n",
       "tweet_author                                        1stOncology   \n",
       "tweet_text    #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "\n",
       "                                  2013-07-12 19:19:42.367813635  \\\n",
       "tweet_author                                          Toby Eyre   \n",
       "tweet_text    #acalabrutinib is a valuable option in pts int...   \n",
       "\n",
       "                                  2013-07-04 12:40:34.334232586  \\\n",
       "tweet_author                                       Lymphoma Hub   \n",
       "tweet_text    NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                  2013-07-04 08:44:42.278539265  \\\n",
       "tweet_author                                       David Ledger   \n",
       "tweet_text    NICE backs AstraZeneca‚Äôs Calquence for CLL htt...   \n",
       "\n",
       "                                  2013-07-04 04:22:03.305394179  \\\n",
       "tweet_author                               N Wales Cancer Forum   \n",
       "tweet_text    This is England for now - these decisions usua...   \n",
       "\n",
       "                                  2013-07-03 21:48:41.159868423  \\\n",
       "tweet_author                     European Pharmaceutical Review   \n",
       "tweet_text    AstraZeneca‚Äôs Calquence (acalabrutinib), a che...   \n",
       "\n",
       "                                  2013-07-03 15:55:15.081797632  \\\n",
       "tweet_author                                     Graham Collins   \n",
       "tweet_text    Superstar @tobyeyre82 responding to the excell...   \n",
       "\n",
       "                                  2013-07-03 04:25:53.837944834  ...  \\\n",
       "tweet_author                                        CLL Ireland  ...   \n",
       "tweet_text    CLL patients all know the drug Ibrutinib and y...  ...   \n",
       "\n",
       "                                  1987-06-22 19:36:28.372967425  \\\n",
       "tweet_author                                          C A R E N   \n",
       "tweet_text    I miss them! üòãüòÜüòÖ\\n\\n#FotoRus #FriendshipForeve...   \n",
       "\n",
       "                                  1987-06-22 13:38:05.220745216  \\\n",
       "tweet_author                                    Werneth Cricket   \n",
       "tweet_text    The fixtures are out, first team will travel t...   \n",
       "\n",
       "                                  1987-06-20 01:14:46.517178368  \\\n",
       "tweet_author                                John P. Leonard, MD   \n",
       "tweet_text    Partnering @GileadSciences &amp;Ono BTKi-combo...   \n",
       "\n",
       "                                  1987-06-19 13:30:22.587748353  \\\n",
       "tweet_author                                 Joy is a Lifestyle   \n",
       "tweet_text    Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "\n",
       "                                  1987-06-19 13:03:48.404117505  \\\n",
       "tweet_author                                         Miche√°l üáÆüá™   \n",
       "tweet_text    What I'd do to go to Gerrard's last game at An...   \n",
       "\n",
       "                                  1987-06-19 12:17:53.643945985  \\\n",
       "tweet_author                                 Joy is a Lifestyle   \n",
       "tweet_text    Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "\n",
       "                                  1987-06-19 12:06:26.675290112  \\\n",
       "tweet_author                                      ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ   \n",
       "tweet_text    Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "\n",
       "                                  1987-06-17 23:05:41.186953217  \\\n",
       "tweet_author                                              IQWiG   \n",
       "tweet_text    Zusatznutzen von #Idelalisib ist weder f√ºr #CL...   \n",
       "\n",
       "                                  1987-06-17 15:18:00.525635584  \\\n",
       "tweet_author                                          Medibooks   \n",
       "tweet_text    #Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...   \n",
       "\n",
       "                                  1987-06-13 10:44:06.537678849  \n",
       "tweet_author                                          Medibooks  \n",
       "tweet_text    #Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...  \n",
       "\n",
       "[2 rows x 43347 columns]"
      ]
     },
     "execution_count": 96,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_json(\"tweets.json\")\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "b83c5bf3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>‚öïÔ∏è Scientists conducted a Phase II study of ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:17:53.643945985</th>\n",
       "      <td>Joy is a Lifestyle</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:06:26.675290112</th>\n",
       "      <td>ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 23:05:41.186953217</th>\n",
       "      <td>IQWiG</td>\n",
       "      <td>Zusatznutzen von #Idelalisib ist weder f√ºr #CL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 15:18:00.525635584</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-13 10:44:06.537678849</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>43347 rows √ó 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "...                                           ...   \n",
       "1987-06-19 12:17:53.643945985  Joy is a Lifestyle   \n",
       "1987-06-19 12:06:26.675290112       ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ   \n",
       "1987-06-17 23:05:41.186953217               IQWiG   \n",
       "1987-06-17 15:18:00.525635584           Medibooks   \n",
       "1987-06-13 10:44:06.537678849           Medibooks   \n",
       "\n",
       "                                                                      tweet_text  \n",
       "2013-07-18 09:39:46.071961602  ‚öïÔ∏è Scientists conducted a Phase II study of ac...  \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...  \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...  \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...  \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...  \n",
       "...                                                                          ...  \n",
       "1987-06-19 12:17:53.643945985  Hanging out with Friends! :) #FF #CLL #Happine...  \n",
       "1987-06-19 12:06:26.675290112  Hanging out with Friends! :) #FF #CLL #Happine...  \n",
       "1987-06-17 23:05:41.186953217  Zusatznutzen von #Idelalisib ist weder f√ºr #CL...  \n",
       "1987-06-17 15:18:00.525635584  #Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...  \n",
       "1987-06-13 10:44:06.537678849  #Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...  \n",
       "\n",
       "[43347 rows x 2 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1 = df.transpose()\n",
    "df1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "0dd5005a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "DatetimeIndex: 43347 entries, 2013-07-18 09:39:46.071961602 to 1987-06-13 10:44:06.537678849\n",
      "Data columns (total 2 columns):\n",
      " #   Column        Non-Null Count  Dtype \n",
      "---  ------        --------------  ----- \n",
      " 0   tweet_author  43347 non-null  object\n",
      " 1   tweet_text    43347 non-null  object\n",
      "dtypes: object(2)\n",
      "memory usage: 2.0+ MB\n"
     ]
    }
   ],
   "source": [
    "df1.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "a2c63ec2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "tweet_author    object\n",
       "tweet_text      object\n",
       "dtype: object"
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "6699a1d3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "tweet_author    0\n",
       "tweet_text      0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "53e4eef5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>‚öïÔ∏è Scientists conducted a Phase II study of ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \n",
       "2013-07-18 09:39:46.071961602  ‚öïÔ∏è Scientists conducted a Phase II study of ac...  \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...  \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...  \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...  \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...  "
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "9ba14565",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Data Cleaning"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "71920f5c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\aravi\\AppData\\Local\\Temp\\ipykernel_26916\\4214830881.py:2: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df1['review_processed'] = df1['tweet_text'].str.replace(\"[^a-zA-Z0-9]\", \" \")\n"
     ]
    }
   ],
   "source": [
    "# Replacing punctuations with space\n",
    "df1['review_processed'] = df1['tweet_text'].str.replace(\"[^a-zA-Z0-9]\", \" \")\n",
    "\n",
    "# Re ordering columns\n",
    "df = df1[['tweet_text','review_processed']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "289258b5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602       Scientists conducted a Phase II study of ac...\n",
       "2013-07-17 03:40:32.173842437    This phase 2 Acalabrutinib Venetoclax  AV  tri...\n",
       "2013-07-15 15:41:16.553048065     NICE backs  AstraZenecas  Calquence for  CLL ...\n",
       "2013-07-12 19:19:42.367813635     acalabrutinib is a valuable option in pts int...\n",
       "2013-07-04 12:40:34.334232586    NICE has recommended the use of acalabrutinib ...\n",
       "                                                       ...                        \n",
       "1987-06-19 12:17:53.643945985    Hanging out with Friends      FF  CLL  Happine...\n",
       "1987-06-19 12:06:26.675290112    Hanging out with Friends      FF  CLL  Happine...\n",
       "1987-06-17 23:05:41.186953217    Zusatznutzen von  Idelalisib ist weder f r  CL...\n",
       "1987-06-17 15:18:00.525635584     Hematolog a PTK2 EXPRESSION AND IMMUNOCHEMOTH...\n",
       "1987-06-13 10:44:06.537678849     Hematolog a MUTATIONS IN TLR MYD88 PATHWAY ID...\n",
       "Name: review_processed, Length: 43347, dtype: object"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['review_processed']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "65abb448",
   "metadata": {},
   "outputs": [],
   "source": [
    "df1['review_processed'] = df1['review_processed'].apply(lambda row: ' '.join([word for word in row.split() if len(word)>2]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "id": "40b442b2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# make entire text lowercase\n",
    "df1['review_processed'] = [row.lower() for row in df1['review_processed']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "d08c7880",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602    scientists conducted phase study acalabrutinib...\n",
       "2013-07-17 03:40:32.173842437    this phase acalabrutinib venetoclax trial that...\n",
       "2013-07-15 15:41:16.553048065    nice backs astrazenecas calquence for cll http...\n",
       "2013-07-12 19:19:42.367813635    acalabrutinib valuable option pts intolerant i...\n",
       "2013-07-04 12:40:34.334232586    nice has recommended the use acalabrutinib for...\n",
       "                                                       ...                        \n",
       "1987-06-19 12:17:53.643945985    hanging out with friends cll happiness http pd...\n",
       "1987-06-19 12:06:26.675290112    hanging out with friends cll happiness http gy...\n",
       "1987-06-17 23:05:41.186953217    zusatznutzen von idelalisib ist weder cll noch...\n",
       "1987-06-17 15:18:00.525635584    hematolog ptk2 expression and immunochemothera...\n",
       "1987-06-13 10:44:06.537678849    hematolog mutations tlr myd88 pathway identify...\n",
       "Name: review_processed, Length: 43347, dtype: object"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['review_processed']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "97736801",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['i',\n",
       " 'me',\n",
       " 'my',\n",
       " 'myself',\n",
       " 'we',\n",
       " 'our',\n",
       " 'ours',\n",
       " 'ourselves',\n",
       " 'you',\n",
       " \"you're\",\n",
       " \"you've\",\n",
       " \"you'll\",\n",
       " \"you'd\",\n",
       " 'your',\n",
       " 'yours',\n",
       " 'yourself',\n",
       " 'yourselves',\n",
       " 'he',\n",
       " 'him',\n",
       " 'his',\n",
       " 'himself',\n",
       " 'she',\n",
       " \"she's\",\n",
       " 'her',\n",
       " 'hers',\n",
       " 'herself',\n",
       " 'it',\n",
       " \"it's\",\n",
       " 'its',\n",
       " 'itself',\n",
       " 'they',\n",
       " 'them',\n",
       " 'their',\n",
       " 'theirs',\n",
       " 'themselves',\n",
       " 'what',\n",
       " 'which',\n",
       " 'who',\n",
       " 'whom',\n",
       " 'this',\n",
       " 'that',\n",
       " \"that'll\",\n",
       " 'these',\n",
       " 'those',\n",
       " 'am',\n",
       " 'is',\n",
       " 'are',\n",
       " 'was',\n",
       " 'were',\n",
       " 'be',\n",
       " 'been',\n",
       " 'being',\n",
       " 'have',\n",
       " 'has',\n",
       " 'had',\n",
       " 'having',\n",
       " 'do',\n",
       " 'does',\n",
       " 'did',\n",
       " 'doing',\n",
       " 'a',\n",
       " 'an',\n",
       " 'the',\n",
       " 'and',\n",
       " 'but',\n",
       " 'if',\n",
       " 'or',\n",
       " 'because',\n",
       " 'as',\n",
       " 'until',\n",
       " 'while',\n",
       " 'of',\n",
       " 'at',\n",
       " 'by',\n",
       " 'for',\n",
       " 'with',\n",
       " 'about',\n",
       " 'against',\n",
       " 'between',\n",
       " 'into',\n",
       " 'through',\n",
       " 'during',\n",
       " 'before',\n",
       " 'after',\n",
       " 'above',\n",
       " 'below',\n",
       " 'to',\n",
       " 'from',\n",
       " 'up',\n",
       " 'down',\n",
       " 'in',\n",
       " 'out',\n",
       " 'on',\n",
       " 'off',\n",
       " 'over',\n",
       " 'under',\n",
       " 'again',\n",
       " 'further',\n",
       " 'then',\n",
       " 'once',\n",
       " 'here',\n",
       " 'there',\n",
       " 'when',\n",
       " 'where',\n",
       " 'why',\n",
       " 'how',\n",
       " 'all',\n",
       " 'any',\n",
       " 'both',\n",
       " 'each',\n",
       " 'few',\n",
       " 'more',\n",
       " 'most',\n",
       " 'other',\n",
       " 'some',\n",
       " 'such',\n",
       " 'no',\n",
       " 'nor',\n",
       " 'not',\n",
       " 'only',\n",
       " 'own',\n",
       " 'same',\n",
       " 'so',\n",
       " 'than',\n",
       " 'too',\n",
       " 'very',\n",
       " 's',\n",
       " 't',\n",
       " 'can',\n",
       " 'will',\n",
       " 'just',\n",
       " 'don',\n",
       " \"don't\",\n",
       " 'should',\n",
       " \"should've\",\n",
       " 'now',\n",
       " 'd',\n",
       " 'll',\n",
       " 'm',\n",
       " 'o',\n",
       " 're',\n",
       " 've',\n",
       " 'y',\n",
       " 'ain',\n",
       " 'aren',\n",
       " \"aren't\",\n",
       " 'couldn',\n",
       " \"couldn't\",\n",
       " 'didn',\n",
       " \"didn't\",\n",
       " 'doesn',\n",
       " \"doesn't\",\n",
       " 'hadn',\n",
       " \"hadn't\",\n",
       " 'hasn',\n",
       " \"hasn't\",\n",
       " 'haven',\n",
       " \"haven't\",\n",
       " 'isn',\n",
       " \"isn't\",\n",
       " 'ma',\n",
       " 'mightn',\n",
       " \"mightn't\",\n",
       " 'mustn',\n",
       " \"mustn't\",\n",
       " 'needn',\n",
       " \"needn't\",\n",
       " 'shan',\n",
       " \"shan't\",\n",
       " 'shouldn',\n",
       " \"shouldn't\",\n",
       " 'wasn',\n",
       " \"wasn't\",\n",
       " 'weren',\n",
       " \"weren't\",\n",
       " 'won',\n",
       " \"won't\",\n",
       " 'wouldn',\n",
       " \"wouldn't\"]"
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Removing Stopwords Begin\n",
    "import nltk\n",
    "nltk.download('punkt')\n",
    "nltk.download('stopwords')\n",
    "from nltk.corpus import stopwords\n",
    "from nltk import word_tokenize\n",
    "\n",
    "stop_words = stopwords.words('english') \n",
    "stop_words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "cda05d60",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "# Removing Stopwords Begin\n",
    "import nltk\n",
    "nltk.download('punkt')\n",
    "nltk.download('stopwords')\n",
    "from nltk.corpus import stopwords\n",
    "from nltk import word_tokenize\n",
    "\n",
    "stop_words = stopwords.words('english') # extracting all the stop words in english language and storing it in a variable called stop_words -> set\n",
    "\n",
    "# Making custom list of words to be removed \n",
    "add_words = ['movie','film','one','make','even','see','movies','get','makes','making','time','watch','character','good','like','well','would']\n",
    "\n",
    "# Adding to the list of words\n",
    "stop_words.extend(add_words)\n",
    "\n",
    "# Function to remove stop words \n",
    "def remove_stopwords(rev):\n",
    "    # iNPUT : IT WILL TAKE ROW/REVIEW AS AN INPUT\n",
    "    # take the paragraph, break into words, check if the word is a stop word, remove if stop word, combine the words into a para again\n",
    "    review_tokenized = word_tokenize(rev)\n",
    "    rev_new = \" \".join([i for i in review_tokenized  if i not in stop_words])\n",
    "    return rev_new\n",
    "\n",
    "# Removing stopwords\n",
    "df1['review_processed'] = [remove_stopwords(r) for r in df1['review_processed']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "baec375e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602    scientists conducted phase study acalabrutinib...\n",
       "2013-07-17 03:40:32.173842437    phase acalabrutinib venetoclax trial still rec...\n",
       "2013-07-15 15:41:16.553048065    nice backs astrazenecas calquence cll https vb...\n",
       "2013-07-12 19:19:42.367813635    acalabrutinib valuable option pts intolerant i...\n",
       "2013-07-04 12:40:34.334232586    nice recommended use acalabrutinib patients tr...\n",
       "                                                       ...                        \n",
       "1987-06-19 12:17:53.643945985        hanging friends cll happiness http pdleww6bbb\n",
       "1987-06-19 12:06:26.675290112        hanging friends cll happiness http gynchdnul2\n",
       "1987-06-17 23:05:41.186953217    zusatznutzen von idelalisib ist weder cll noch...\n",
       "1987-06-17 15:18:00.525635584    hematolog ptk2 expression immunochemotherapy o...\n",
       "1987-06-13 10:44:06.537678849    hematolog mutations tlr myd88 pathway identify...\n",
       "Name: review_processed, Length: 43347, dtype: object"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['review_processed']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "id": "8876ddfa",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package wordnet to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package wordnet is already up-to-date!\n",
      "[nltk_data] Downloading package omw-1.4 to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package omw-1.4 is already up-to-date!\n",
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     C:\\Users\\aravi\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package averaged_perceptron_tagger is already up-to-\n",
      "[nltk_data]       date!\n"
     ]
    }
   ],
   "source": [
    "# Begin Lemmatization \n",
    "nltk.download('wordnet')\n",
    "nltk.download('omw-1.4')\n",
    "nltk.download('averaged_perceptron_tagger')\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from nltk.corpus import wordnet\n",
    "\n",
    "# function to convert nltk tag to wordnet tag\n",
    "lemmatizer = WordNetLemmatizer()\n",
    "\n",
    "# Finds the part of speech tag\n",
    "# Convert the detailed POS tag into a shallow information\n",
    "def nltk_tag_to_wordnet_tag(nltk_tag):\n",
    "    if nltk_tag.startswith('J'):\n",
    "        return wordnet.ADJ\n",
    "    elif nltk_tag.startswith('V'):\n",
    "        return wordnet.VERB\n",
    "    elif nltk_tag.startswith('N'):\n",
    "        return wordnet.NOUN\n",
    "    elif nltk_tag.startswith('R'):\n",
    "        return wordnet.ADV\n",
    "    else:          \n",
    "        return None\n",
    "\n",
    "# lemmatize sentence using pos tag\n",
    "def lemmatize_sentence(sentence):\n",
    "  # word tokenize -> pos tag (detailed) -> wordnet tag (shallow pos) -> lemmatizer -> root word\n",
    "    #tokenize the sentence and find the POS tag for each token\n",
    "    nltk_tagged = nltk.pos_tag(nltk.word_tokenize(sentence))  # output will be a list of tuples -> [(word,detailed_tag)]\n",
    "    #tuple of (token, wordnet_tag)\n",
    "    wordnet_tagged = map(lambda x: (x[0], nltk_tag_to_wordnet_tag(x[1])), nltk_tagged) # output -> [(word,shallow_tag)]\n",
    "    lemmatized_sentence = []\n",
    "    for word, tag in wordnet_tagged:\n",
    "        if tag is None:\n",
    "            #if there is no available tag, append the token as is\n",
    "            lemmatized_sentence.append(word)\n",
    "        else:        \n",
    "            #else use the tag to lemmatize the token\n",
    "            lemmatized_sentence.append(lemmatizer.lemmatize(word, tag))\n",
    "    return \" \".join(lemmatized_sentence)\n",
    "\n",
    "\n",
    "df1['review_processed'] = df1['review_processed'].apply(lambda x: lemmatize_sentence(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "id": "79308001",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602    scientist conduct phase study acalabrutinib pa...\n",
       "2013-07-17 03:40:32.173842437    phase acalabrutinib venetoclax trial still rec...\n",
       "2013-07-15 15:41:16.553048065    nice back astrazenecas calquence cll http vb5l...\n",
       "2013-07-12 19:19:42.367813635    acalabrutinib valuable option pt intolerant ib...\n",
       "2013-07-04 12:40:34.334232586    nice recommend use acalabrutinib patient treat...\n",
       "                                                       ...                        \n",
       "1987-06-19 12:17:53.643945985            hang friend cll happiness http pdleww6bbb\n",
       "1987-06-19 12:06:26.675290112            hang friend cll happiness http gynchdnul2\n",
       "1987-06-17 23:05:41.186953217    zusatznutzen von idelalisib ist weder cll noch...\n",
       "1987-06-17 15:18:00.525635584    hematolog ptk2 expression immunochemotherapy o...\n",
       "1987-06-13 10:44:06.537678849    hematolog mutation tlr myd88 pathway identify ...\n",
       "Name: review_processed, Length: 43347, dtype: object"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1['review_processed']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "d9b6dbcb",
   "metadata": {},
   "outputs": [],
   "source": [
    "from textblob import TextBlob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "id": "23c2a15a",
   "metadata": {},
   "outputs": [],
   "source": [
    "def subject(text):\n",
    "    return TextBlob(text).sentiment.subjectivity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "id": "32c9c8f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df1['Subjectivity'] = df1['review_processed'].apply(subject)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "id": "704dc3a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a function to get the Polarity\n",
    "def polar(text1):\n",
    "    return TextBlob(text1).sentiment.polarity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "dfefd9c6",
   "metadata": {},
   "outputs": [],
   "source": [
    "df1['Polarity'] = df1['review_processed'].apply(polar)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "9bcfc496",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>review_processed</th>\n",
       "      <th>Subjectivity</th>\n",
       "      <th>Polarity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>‚öïÔ∏è Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientist conduct phase study acalabrutinib pa...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>phase acalabrutinib venetoclax trial still rec...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice back astrazenecas calquence cll http vb5l...</td>\n",
       "      <td>0.5</td>\n",
       "      <td>0.3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib valuable option pt intolerant ib...</td>\n",
       "      <td>0.3</td>\n",
       "      <td>0.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice recommend use acalabrutinib patient treat...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:17:53.643945985</th>\n",
       "      <td>Joy is a Lifestyle</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>hang friend cll happiness http pdleww6bbb</td>\n",
       "      <td>0.2</td>\n",
       "      <td>0.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:06:26.675290112</th>\n",
       "      <td>ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>hang friend cll happiness http gynchdnul2</td>\n",
       "      <td>0.2</td>\n",
       "      <td>0.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 23:05:41.186953217</th>\n",
       "      <td>IQWiG</td>\n",
       "      <td>Zusatznutzen von #Idelalisib ist weder f√ºr #CL...</td>\n",
       "      <td>zusatznutzen von idelalisib ist weder cll noch...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 15:18:00.525635584</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...</td>\n",
       "      <td>hematolog ptk2 expression immunochemotherapy o...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-13 10:44:06.537678849</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...</td>\n",
       "      <td>hematolog mutation tlr myd88 pathway identify ...</td>\n",
       "      <td>0.4</td>\n",
       "      <td>0.1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>43347 rows √ó 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "...                                           ...   \n",
       "1987-06-19 12:17:53.643945985  Joy is a Lifestyle   \n",
       "1987-06-19 12:06:26.675290112       ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ   \n",
       "1987-06-17 23:05:41.186953217               IQWiG   \n",
       "1987-06-17 15:18:00.525635584           Medibooks   \n",
       "1987-06-13 10:44:06.537678849           Medibooks   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ‚öïÔ∏è Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "...                                                                          ...   \n",
       "1987-06-19 12:17:53.643945985  Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "1987-06-19 12:06:26.675290112  Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "1987-06-17 23:05:41.186953217  Zusatznutzen von #Idelalisib ist weder f√ºr #CL...   \n",
       "1987-06-17 15:18:00.525635584  #Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...   \n",
       "1987-06-13 10:44:06.537678849  #Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...   \n",
       "\n",
       "                                                                review_processed  \\\n",
       "2013-07-18 09:39:46.071961602  scientist conduct phase study acalabrutinib pa...   \n",
       "2013-07-17 03:40:32.173842437  phase acalabrutinib venetoclax trial still rec...   \n",
       "2013-07-15 15:41:16.553048065  nice back astrazenecas calquence cll http vb5l...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib valuable option pt intolerant ib...   \n",
       "2013-07-04 12:40:34.334232586  nice recommend use acalabrutinib patient treat...   \n",
       "...                                                                          ...   \n",
       "1987-06-19 12:17:53.643945985          hang friend cll happiness http pdleww6bbb   \n",
       "1987-06-19 12:06:26.675290112          hang friend cll happiness http gynchdnul2   \n",
       "1987-06-17 23:05:41.186953217  zusatznutzen von idelalisib ist weder cll noch...   \n",
       "1987-06-17 15:18:00.525635584  hematolog ptk2 expression immunochemotherapy o...   \n",
       "1987-06-13 10:44:06.537678849  hematolog mutation tlr myd88 pathway identify ...   \n",
       "\n",
       "                               Subjectivity  Polarity  \n",
       "2013-07-18 09:39:46.071961602           0.0       0.0  \n",
       "2013-07-17 03:40:32.173842437           0.0       0.0  \n",
       "2013-07-15 15:41:16.553048065           0.5       0.3  \n",
       "2013-07-12 19:19:42.367813635           0.3       0.1  \n",
       "2013-07-04 12:40:34.334232586           1.0       0.6  \n",
       "...                                     ...       ...  \n",
       "1987-06-19 12:17:53.643945985           0.2       0.7  \n",
       "1987-06-19 12:06:26.675290112           0.2       0.7  \n",
       "1987-06-17 23:05:41.186953217           0.0       0.0  \n",
       "1987-06-17 15:18:00.525635584           0.0       0.0  \n",
       "1987-06-13 10:44:06.537678849           0.4       0.1  \n",
       "\n",
       "[43347 rows x 5 columns]"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "ee8ee38b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a functin to compute the negative, neutral and positive analysis\n",
    "def tweet_Analysis(score):\n",
    "    if score == 0:\n",
    "        return 'neutral'\n",
    "    elif score < 0 :\n",
    "        return 'negative' \n",
    "    else:\n",
    "        return 'Positive'\n",
    "df1['Analysis'] = df1['Polarity'].apply(tweet_Analysis)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "28b44197",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>review_processed</th>\n",
       "      <th>Subjectivity</th>\n",
       "      <th>Polarity</th>\n",
       "      <th>Analysis</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>‚öïÔ∏è Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientist conduct phase study acalabrutinib pa...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>phase acalabrutinib venetoclax trial still rec...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice back astrazenecas calquence cll http vb5l...</td>\n",
       "      <td>0.5</td>\n",
       "      <td>0.3</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib valuable option pt intolerant ib...</td>\n",
       "      <td>0.3</td>\n",
       "      <td>0.1</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice recommend use acalabrutinib patient treat...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:17:53.643945985</th>\n",
       "      <td>Joy is a Lifestyle</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>hang friend cll happiness http pdleww6bbb</td>\n",
       "      <td>0.2</td>\n",
       "      <td>0.7</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-19 12:06:26.675290112</th>\n",
       "      <td>ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ</td>\n",
       "      <td>Hanging out with Friends! :) #FF #CLL #Happine...</td>\n",
       "      <td>hang friend cll happiness http gynchdnul2</td>\n",
       "      <td>0.2</td>\n",
       "      <td>0.7</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 23:05:41.186953217</th>\n",
       "      <td>IQWiG</td>\n",
       "      <td>Zusatznutzen von #Idelalisib ist weder f√ºr #CL...</td>\n",
       "      <td>zusatznutzen von idelalisib ist weder cll noch...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-17 15:18:00.525635584</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...</td>\n",
       "      <td>hematolog ptk2 expression immunochemotherapy o...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1987-06-13 10:44:06.537678849</th>\n",
       "      <td>Medibooks</td>\n",
       "      <td>#Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...</td>\n",
       "      <td>hematolog mutation tlr myd88 pathway identify ...</td>\n",
       "      <td>0.4</td>\n",
       "      <td>0.1</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>43347 rows √ó 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "...                                           ...   \n",
       "1987-06-19 12:17:53.643945985  Joy is a Lifestyle   \n",
       "1987-06-19 12:06:26.675290112       ùìíùìªùì≤ùîÉùîÉùîÇ ùìüùìÆùìªùìªùîÇüåπ   \n",
       "1987-06-17 23:05:41.186953217               IQWiG   \n",
       "1987-06-17 15:18:00.525635584           Medibooks   \n",
       "1987-06-13 10:44:06.537678849           Medibooks   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ‚öïÔ∏è Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "...                                                                          ...   \n",
       "1987-06-19 12:17:53.643945985  Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "1987-06-19 12:06:26.675290112  Hanging out with Friends! :) #FF #CLL #Happine...   \n",
       "1987-06-17 23:05:41.186953217  Zusatznutzen von #Idelalisib ist weder f√ºr #CL...   \n",
       "1987-06-17 15:18:00.525635584  #Hematolog√≠a PTK2 EXPRESSION AND IMMUNOCHEMOTH...   \n",
       "1987-06-13 10:44:06.537678849  #Hematolog√≠a MUTATIONS IN TLR/MYD88 PATHWAY ID...   \n",
       "\n",
       "                                                                review_processed  \\\n",
       "2013-07-18 09:39:46.071961602  scientist conduct phase study acalabrutinib pa...   \n",
       "2013-07-17 03:40:32.173842437  phase acalabrutinib venetoclax trial still rec...   \n",
       "2013-07-15 15:41:16.553048065  nice back astrazenecas calquence cll http vb5l...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib valuable option pt intolerant ib...   \n",
       "2013-07-04 12:40:34.334232586  nice recommend use acalabrutinib patient treat...   \n",
       "...                                                                          ...   \n",
       "1987-06-19 12:17:53.643945985          hang friend cll happiness http pdleww6bbb   \n",
       "1987-06-19 12:06:26.675290112          hang friend cll happiness http gynchdnul2   \n",
       "1987-06-17 23:05:41.186953217  zusatznutzen von idelalisib ist weder cll noch...   \n",
       "1987-06-17 15:18:00.525635584  hematolog ptk2 expression immunochemotherapy o...   \n",
       "1987-06-13 10:44:06.537678849  hematolog mutation tlr myd88 pathway identify ...   \n",
       "\n",
       "                               Subjectivity  Polarity  Analysis  \n",
       "2013-07-18 09:39:46.071961602           0.0       0.0   neutral  \n",
       "2013-07-17 03:40:32.173842437           0.0       0.0   neutral  \n",
       "2013-07-15 15:41:16.553048065           0.5       0.3  Positive  \n",
       "2013-07-12 19:19:42.367813635           0.3       0.1  Positive  \n",
       "2013-07-04 12:40:34.334232586           1.0       0.6  Positive  \n",
       "...                                     ...       ...       ...  \n",
       "1987-06-19 12:17:53.643945985           0.2       0.7  Positive  \n",
       "1987-06-19 12:06:26.675290112           0.2       0.7  Positive  \n",
       "1987-06-17 23:05:41.186953217           0.0       0.0   neutral  \n",
       "1987-06-17 15:18:00.525635584           0.0       0.0   neutral  \n",
       "1987-06-13 10:44:06.537678849           0.4       0.1  Positive  \n",
       "\n",
       "[43347 rows x 6 columns]"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "id": "65032b22",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>frequency</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>entity</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>chronic lymphocytic leukemia</th>\n",
       "      <td>80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new cll research study available placebo qualify http obiujz9nkl</th>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>look new solution cll patientpower explores cll treatment expert jeff sharman check http yg2es5nxlk</th>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chronic lymphocytic leukemia cll hypogammaglobulinemia</th>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>relapse cll new trial actively enrol placebo learn http aeftgbuckm</th>\n",
       "      <td>42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http xsqydbg8pq news pharma pharmiweb</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http fycdmzzukg news pharma pharmiweb</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>roche announces update data two novel chronic lymphocytic leukemia treatment combination ash19 https zgievri7k7 rhhby rog https 3kbnebkjec</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http uhowjh7ymz</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hematolog mutation tlr myd88 pathway identify subset young chronic lymphocytic leukemia patient http yzvk2n9usz</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>41355 rows √ó 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    frequency\n",
       "entity                                                       \n",
       "chronic lymphocytic leukemia                               80\n",
       "new cll research study available placebo qualif...         69\n",
       "look new solution cll patientpower explores cll...         65\n",
       "chronic lymphocytic leukemia cll hypogammaglobu...         58\n",
       "relapse cll new trial actively enrol placebo le...         42\n",
       "...                                                       ...\n",
       "new long term data continue demonstrate progres...          1\n",
       "new long term data continue demonstrate progres...          1\n",
       "roche announces update data two novel chronic l...          1\n",
       "new long term data continue demonstrate progres...          1\n",
       "hematolog mutation tlr myd88 pathway identify s...          1\n",
       "\n",
       "[41355 rows x 1 columns]"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freq = df1.review_processed.value_counts().rename_axis('entity').to_frame('frequency')\n",
    "freq"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "id": "77bc6431",
   "metadata": {},
   "outputs": [],
   "source": [
    "freq.to_csv(\"C:\\\\Users\\\\aravi\\\\Desktop\\\\arun_assig\\\\Interview Ques\\\\objective1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "aa1e88ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "df1.review_processed.value_counts().rename_axis('entity').to_frame('frequency')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "id": "7263764e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\aravi\\AppData\\Local\\Temp\\ipykernel_26916\\666762211.py:1: FutureWarning: Dropping invalid columns in DataFrameGroupBy.mean is deprecated. In a future version, a TypeError will be raised. Before calling .mean, select only columns which should be valid for the function.\n",
      "  df1[[\"tweet_author\",\"review_processed\",\"Analysis\"]].groupby([\"tweet_author\"]).mean()\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tweet_author</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Camilla White</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Emilie Thompson</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Hannah Wright</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Yvianna   Ô£ø</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>#DestroyTheAadhaar    TwiLightOFTheGODS</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ü•∂</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ü¶ãNasRafü¶ã</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ü¶ìü¶ì H√∂micidal Barcode ü¶ìü¶ì</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>üß¨ Adam Grant</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ü™êManuela</th>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>9292 rows √ó 0 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: []\n",
       "Index: [ Camilla White,  Emilie Thompson,  Hannah Wright,  Yvianna   Ô£ø, #DestroyTheAadhaar    TwiLightOFTheGODS, #Endsars protest, #Enritchansrajpandey, #KING OF FLORIDA üëë, #LeoWeichafe, #Memory, #MondayNightIBD, #SiguemeYTeSigoDeVuelta, #StrawbeibeePinküçìüç´üçìüç´üçì#Champagneüåπüçæüíãü•Ç‚ù§, #WeAreE4H, $PENNY KING, $Stocknewsalerts, (((Ed Moran))), (((Julianna Shapiro))), (((Rich Stein)))Stay safeüò∑ü¶† & be kind, (((Wendi))), (bio)technerd, *, ****, *–¶–∏—Ç–∞—Ç—ã*, +Recortes Salvajes, ., ..., 01581Psychotherapy, 105.3 The FOX, 10x Genomics, 11 Health, 1147 001, 123ewq21, 13WREX, 19health, 1ClickRepeater, 1MarketResearch.com, 1Mcancerprayers, 1stChoiceIntl., 1stOncology, 2 Minute Medicine¬Æ, 21, 24H Sante, 3'z Company YT, 360WiseBHAM ¬Æ, 380, 3@amritsood1, 3BL Health, 3PSolution, 3novices, 40:40 Recruitment, 420 Ag, 48remont-10, 48remont-11, 48remont-12, 48remont4, 48remont7, 4ID SCIENCE, 4Locum, 4RXCard, 4StateNews, 5hmCpapers, 60s Folks, 660 NEWS Calgary, 6HN Oncology Nurses, 7NEWS Sydney, 7thSpace Interactive, 8 Pack Abs, 84$$ ¬Æ, 92 News HD Plus, 97.3 The Wave News, 984 pharmacy, 9Dimen Group, 9News Sydney, @ Robert, @AplusA_France, @COVID_Evidence, @Clinical Practice, @CurlieCutiePie, @EPMScientific, @Easy_Branches #guestpostingservices, @EbruTVKenya, @INSIGHTHealth, @MissKonfidentielle üîÜ Val√©rie Desforges, @MyelomaTeacher - Cindy Chmielewski, @ReportsandMarkets, @ScottWaudbyHaemResLeics, @URHemOncFellows, @balbensi üá∫üá∏ üáÆüáπ, @diario24horas, @fechacochaco, @globalfirstnews, @gulleyj1, @immunoonco_Meed, @investigando, @linfopedia, @mariuskarma, @nnystar, @scipak_es, @sehh_es, ...]\n",
       "\n",
       "[9292 rows x 0 columns]"
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1[[\"tweet_author\",\"review_processed\",\"Analysis\"]].groupby([\"tweet_author\"]).mean()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "id": "853255de",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>frequency</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>entity</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>chronic lymphocytic leukemia</th>\n",
       "      <td>80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new cll research study available placebo qualify http obiujz9nkl</th>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>look new solution cll patientpower explores cll treatment expert jeff sharman check http yg2es5nxlk</th>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chronic lymphocytic leukemia cll hypogammaglobulinemia</th>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>relapse cll new trial actively enrol placebo learn http aeftgbuckm</th>\n",
       "      <td>42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http xsqydbg8pq news pharma pharmiweb</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http fycdmzzukg news pharma pharmiweb</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>roche announces update data two novel chronic lymphocytic leukemia treatment combination ash19 https zgievri7k7 rhhby rog https 3kbnebkjec</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>new long term data continue demonstrate progression free survival overall survival benefit venclexta venclyxto venetoclax combination patient relapse refractory chronic lymphocytic leukemia cll http uhowjh7ymz</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hematolog mutation tlr myd88 pathway identify subset young chronic lymphocytic leukemia patient http yzvk2n9usz</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>41355 rows √ó 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    frequency\n",
       "entity                                                       \n",
       "chronic lymphocytic leukemia                               80\n",
       "new cll research study available placebo qualif...         69\n",
       "look new solution cll patientpower explores cll...         65\n",
       "chronic lymphocytic leukemia cll hypogammaglobu...         58\n",
       "relapse cll new trial actively enrol placebo le...         42\n",
       "...                                                       ...\n",
       "new long term data continue demonstrate progres...          1\n",
       "new long term data continue demonstrate progres...          1\n",
       "roche announces update data two novel chronic l...          1\n",
       "new long term data continue demonstrate progres...          1\n",
       "hematolog mutation tlr myd88 pathway identify s...          1\n",
       "\n",
       "[41355 rows x 1 columns]"
      ]
     },
     "execution_count": 134,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freq"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5dd15458",
   "metadata": {},
   "outputs": [],
   "source": [
    "#trail:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "id": "86c77d6c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def subject(tweet):\n",
    "    return TextBlob(tweet).sentiment.subjectivity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "id": "325a1812",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a function to get the Polarity\n",
    "def polar(text1):\n",
    "    return TextBlob(text1).sentiment.polarity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "id": "dc1e17c7",
   "metadata": {},
   "outputs": [],
   "source": [
    "freq['Polarity'] = freq[\"entity\"].apply(polar)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "id": "38c5167d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a functin to compute the negative, neutral and positive analysis\n",
    "def tweet_Analysis(score):\n",
    "    if score == 0:\n",
    "        return 'neutral'\n",
    "    elif score < 0 :\n",
    "        return 'negative' \n",
    "    else:\n",
    "        return 'Positive'\n",
    "freq['Analysis'] = freq[\"Polarity\"].apply(tweet_Analysis)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "id": "72b58904",
   "metadata": {},
   "outputs": [],
   "source": [
    "freq.reset_index(inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "id": "af8ade18",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                             chronic lymphocytic leukemia\n",
       "1        new cll research study available placebo quali...\n",
       "2        look new solution cll patientpower explores cl...\n",
       "3        chronic lymphocytic leukemia cll hypogammaglob...\n",
       "4        relapse cll new trial actively enrol placebo l...\n",
       "                               ...                        \n",
       "41350    new long term data continue demonstrate progre...\n",
       "41351    new long term data continue demonstrate progre...\n",
       "41352    roche announces update data two novel chronic ...\n",
       "41353    new long term data continue demonstrate progre...\n",
       "41354    hematolog mutation tlr myd88 pathway identify ...\n",
       "Name: entity, Length: 41355, dtype: object"
      ]
     },
     "execution_count": 145,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freq[\"entity\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "id": "8cfbb41a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>entity</th>\n",
       "      <th>frequency</th>\n",
       "      <th>Polarity</th>\n",
       "      <th>Analysis</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>80</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>new cll research study available placebo quali...</td>\n",
       "      <td>69</td>\n",
       "      <td>0.268182</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>look new solution cll patientpower explores cl...</td>\n",
       "      <td>65</td>\n",
       "      <td>0.136364</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>chronic lymphocytic leukemia cll hypogammaglob...</td>\n",
       "      <td>58</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>relapse cll new trial actively enrol placebo l...</td>\n",
       "      <td>42</td>\n",
       "      <td>0.001515</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41350</th>\n",
       "      <td>new long term data continue demonstrate progre...</td>\n",
       "      <td>1</td>\n",
       "      <td>0.121591</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41351</th>\n",
       "      <td>new long term data continue demonstrate progre...</td>\n",
       "      <td>1</td>\n",
       "      <td>0.121591</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41352</th>\n",
       "      <td>roche announces update data two novel chronic ...</td>\n",
       "      <td>1</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41353</th>\n",
       "      <td>new long term data continue demonstrate progre...</td>\n",
       "      <td>1</td>\n",
       "      <td>0.121591</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41354</th>\n",
       "      <td>hematolog mutation tlr myd88 pathway identify ...</td>\n",
       "      <td>1</td>\n",
       "      <td>0.100000</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>41355 rows √ó 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  entity  frequency  Polarity  \\\n",
       "0                           chronic lymphocytic leukemia         80  0.000000   \n",
       "1      new cll research study available placebo quali...         69  0.268182   \n",
       "2      look new solution cll patientpower explores cl...         65  0.136364   \n",
       "3      chronic lymphocytic leukemia cll hypogammaglob...         58  0.000000   \n",
       "4      relapse cll new trial actively enrol placebo l...         42  0.001515   \n",
       "...                                                  ...        ...       ...   \n",
       "41350  new long term data continue demonstrate progre...          1  0.121591   \n",
       "41351  new long term data continue demonstrate progre...          1  0.121591   \n",
       "41352  roche announces update data two novel chronic ...          1  0.000000   \n",
       "41353  new long term data continue demonstrate progre...          1  0.121591   \n",
       "41354  hematolog mutation tlr myd88 pathway identify ...          1  0.100000   \n",
       "\n",
       "       Analysis  \n",
       "0       neutral  \n",
       "1      Positive  \n",
       "2      Positive  \n",
       "3       neutral  \n",
       "4      Positive  \n",
       "...         ...  \n",
       "41350  Positive  \n",
       "41351  Positive  \n",
       "41352   neutral  \n",
       "41353  Positive  \n",
       "41354  Positive  \n",
       "\n",
       "[41355 rows x 4 columns]"
      ]
     },
     "execution_count": 155,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freq"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bcd3867e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ed4e1f16",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
